Clinical Trial Update: Study of Axitinib for Reducing Extent of Venous Tumour Thrombus in Renal Cancer With Venous Invasion [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating axitinib for reducing extent of venous tumor thrombus in renal cell carcinoma with venous invasion has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Axitinib (Axitinib)

Snippet

Sponsor: Scottish Clinical Trials Research Unit | Conditions: Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2021-06-30